Active Studies

Principal Investigator: Angela Wangari Walter, Ph.D., MPH

Project Director: Brett Goshe, Ph.D.

Study Sites: NCORP Community Sites and Minority/Underserved Community Sites

Study Coordinator: Gabbie Nicolosi, B.A.

Funding Source: NCI

Study Description:

This diversity supplement enhances the clinical trial for the parent grant (R01CA214427; MPIs Drs. E. Park & J. Ostroff MPIs) by examining organizational contexts that influence adoption of tobacco use assessment and treatment interventions; and identifying strategies to facilitate implementation of evidence-based tobacco treatment interventions in community cancer care settings.

Principal Investigator(s): Elyse Park, Ph.D.; Nancy Rigotti, M.D.; Jennifer Haas, M.D.

Project Manager: Amy Wint, M.S.

Study Sites: BWH Faulkner, MGH Chelsea, MGH Danvers, NWH Main, MGH Waltham, MGH Main: Yawkey 6, MGH Main: Blake 2; currently adding Martha’s Vineyard (MVH) and may add Cooley Dickinson

Study Coordinator(s): Caylin Marotta, B.A.; Elise Noonan, B.A.; Cayley Bliss, B.A.

Funding Source: NIH / NCI RO1

Study Description:

The trial offers tobacco cessation treatment to smokers having a lung cancer screening test.  It is designed to help us meet the U.S. Preventive Services Task Force recommendation to offer smoking cessation as part of lung cancer screening. Screen ASSIST will identify current smokers who schedule a lung cancer screening test and offer them participation in a smoking cessation study. All study participants will receive evidence-based cessation treatment at no cost.  The goal is to identify the most effective combination of (1) tobacco cessation counseling (4 vs. 8 sessions); (2) nicotine replacement (2 vs. 8 weeks); and referral to a community-based resource to address social stresses that make quitting difficult (referral vs. no referral).  Smoking status (primary outcome) will be measured at 6-month follow-up.

Principal Investigator(s): Elyse Park, Ph.D.; Giselle Perez, Ph.D.

Patient Navigator: Allyson Foor, B.A.

Study Sites: Affiliate St. Jude’s Cancer Research Center sites

Project Manager: Calli Mitchell, M.P.H.

Study Coordinator(s): Natalie Durieux, B.S.

Funding Source: American Cancer Society

Study Description:

Dr. Park and her colleagues published findings in the Journal of Clinical Oncology demonstrating that CCSS survivors, compared to siblings, were significantly more likely to be uninsured and to have difficulties obtaining health insurance. Given the current insurance landscape and the additional insurance burden that childhood cancer survivors face, the present study seeks to develop and pilot a health insurance navigation program targeted at feasibility and acceptability with survivors and improving health insurance literacy and ameliorating financial distress related to medical costs. The proposed health insurance navigation will involve 4 navigator-led health insurance navigation sessions. The study investigators propose that, compared to the control arm (who will receive a health insurance information guide, but will not receive the navigation intervention), participants in the intervention arm will have improved health insurance literacy and decreased financial distress related to medical costs.

Principal Investigator(s): Elyse Park, Ph.D.; Giselle Perez, Ph.D.

Patient Navigator: Allyson Foor, B.A.

Study Sites: MGH

Project Manager: Calli Mitchell, M.P.H.

Study Coordinator(s): Natalie Durieux, B.S.

Funding Source: ECOG-ACRIN

Study Description:

This trial aims to assess the feasibility and acceptability of colorectal survivors approached and engaged in HINT and aims to assess the preliminary efficacy of HINT to improve 1) health insurance literacy and 2) financial burden related to medical cost concerns colorectal survivors. The study investigators propose that, compared to the control arm (who will receive a health insurance information guide, but will not receive the navigation intervention), participants in the HINT intervention arm will have improved health insurance literacy and decreased financial distress related to medical costs.

Principal Investigator(s): Elyse Park, Ph.D.; Giselle Perez, Ph.D.

Patient Navigator: Allyson Foor, B.A.

Study Sites: Affiliate St. Jude’s Cancer Research Center sites

Project Manager: Calli Mitchell, M.P.H.

Study Coordinator: Natalie Durieux, B.S.

Funding Source: NCI

Study Description:

We are conducting a Type I hybrid effectiveness-implementation trial to assess the effectiveness of HINT-S compared to enhanced usual care (EUC) in promoting health insurance literacy, thus reducing worry, unmet health care needs, and financial consequences due to medical costs to improve care and long-term outcomes of childhood cancer survivors. While this synchronous intervention is individualized, an asynchronous intervention may be more cost-effective and scalable. Thus, we will also compare HINT-S to HINT-A, a prerecorded, asynchronous version of the 5 HINT-S navigator sessions. Potential participants will complete an electronic screen, consent, and baseline survey and then will be randomized to one of three treatment arm (HINT-S, HINT-A, or EUC). All participants will complete surveys at baseline, 6, 12, and an 18-month follow-up and will receive $20 for each survey. A rigorous implementation evaluation will be conducted.

Principal Investigator: Daniel L. Hall, Ph.D.

Project Director: n/a

Study Sites: MGH and BIDMC (DF/HCC)

Study Coordinator: Michaela Markwart, B.A.

Funding Source: National Center for Complementary and Integrative Health

Study Description:

This is a 5-year study to adapt and pilot test a virtual, multimodal mind-body resiliency intervention (SMART-3RP) to help cancer survivors manage fear of recurrence (FOR). FOR is a common, highly distressing difficulty after diagnosis of a chronic and/or life- threatening illness that may increase risk for poorer clinical outcomes by influencing healthcare engagement (e.g., frequency of follow-up screening). Among cancer survivors, a population growing in prevalence, clinically impairing FOR is pervasive and can persist for years. Using qualitative and quantitative methods, this project will assess the feasibility and acceptability of an adapted mind-body intervention targeting FOR among cancer survivors and will inform the science of managing these fears and their clinical consequences among medical populations more broadly. Phase 1 of this study included focus groups and individual interviews with cancer survivors to identify targets for adaptation, including FOR-related coping and healthcare engagement patterns. Phase 2 is testing the feasibility of the adapted intervention in a pilot RCT and will explore preliminary effects on FOR and healthcare engagement outcomes.

Principal Investigator: Daniel L. Hall, Ph.D.

Project Director: n/a

Study Sites: MGH (DF/HCC)

Study Coordinator: Michaela Markwart, B.A.

Funding Source:  MGH Institutional Research Grant

Study Description:

This is a study to test the feasibility, acceptability, and preliminary effects of a synchronous, virtual cognitive behavioral therapy for insomnia (CBT-I) program for cancer survivors. Insomnia is a significant and often unaddressed problem for adults treated for various types of cancer, with a prevalence rate (30-50%) approximately three times as high as in the general population. CBT-I is a safe, highly effective, and affordable treatment for insomnia that may be delivered to patients in as few as four sessions; however, attrition is common, and engaging patients may require a patient-centered approach.

Using qualitative and quantitative methods, this project aims to adapt CBT-I to address survivor late effects and unique sleep related concerns, via synchronous, virtual technology (e.g., Zoom). Phase 1 of this study included 10 individual interviews with cancer survivors with insomnia to identify perceived needs and preferences for virtually delivered CBT-I. Phase 2 tested the feasibility, acceptability, and preliminary efficacy of the Survivorship Sleep Program in a pilot RCT.

Principal Investigator(s): Nancy Rigotti, M.D.; Eden Evins, M.D.

Project Director: Joanna Streck, Ph.D.

Study Sites: MGH

Study Coordinator: Michael Werner, B.A.

Funding Source: NIDA K12 DA043490

Study Description:

Mixed-methods cross-sectional study to examine tobacco use and treatment attitudes by SUD peer recovery coaches.

Principal Investigator(s): Christina Luberto, Ph.D.

Project Director: n/a

Study Site: MGH Mongan Institute

Study Coordinator: Joanna Cloutier, B.A.

Funding Source: NIH/NIA

Study Description:

Spontaneous coronary artery dissection (SCAD) is an important cause of cardiac events, primarily affecting young healthy women with no cardiovascular risk factors. Approximately half of SCAD survivors struggle with significant anxiety and fear of recurrence (FOR), which contributes to poor sleep and physical inactivity and, thereby, increased risk of recurrence. Mindfulness-Based Cognitive Therapy (MBCT) is an 8-week group intervention with evidence to improve FOR and health behaviors (sleep, physical activity), through psychological mechanisms that directly target key FOR processes. We adapted MBCT to target FOR, sleep, and physical activity in cardiac event survivors via group videoconferencing delivery (UpBeat-MBCT). In this open pilot trial, we will test the feasibility, acceptability, and changes in psychological and behavioral health variables in SCAD survivors participating in UpBeat-MBCT (N=16). The primary outcomes are feasibility and acceptability of the intervention and research procedures. Exploratory outcomes are changes in psychological and behavioral variables and their inter-correlations. This project is the first behavioral intervention for SCAD survivors and will provide preliminary data for an NIH Stage II efficacy trial to develop an accessible and efficacious intervention for a vulnerable group of SCAD survivors, with generalizability to survivors of other cardiac events.

Principal Investigator(s): Christina Luberto, Ph.D.

Project Director: n/a

Study Site: MGH Mongan Institute

Study Coordinator: Joanna Cloutier, B.A.

Funding Source: NIH/NCCIH

Study Description:

Among the one million ACS patients in the U.S. each year (e.g., myocardial infarction, unstable angina), up to 45% have elevated depression symptoms. Even mild elevations in depression symptoms double the risk of mortality after ACS. Mindfulness-Based Cognitive Therapy (MBCT) could improve depression and cardiac health for ACS patients. MBCT is an 8-week manualized group intervention that combines CBT with mindfulness meditation to treat depression. The aim of this study is to establish, in a pilot RCT (approx. N=50 participants) with a time- and attention-matched health enhancement control, (a) the feasibility of the recruitment procedures, the feasibility and acceptability of the (b) MBCT and control interventions and (c) data collection procedures by group. Hypothesis 1a: Recruitment will be feasible as evidenced by screening, eligibility, and enrollment rates; (1b) the MBCT and control interventions and (1c) data collection procedures in both groups will be feasible and acceptable.

Principal Investigator(s): Kelly Irwin, M.D., MPH

Project Director: Samar Shaqour, B.S.

Study Sites: MGH

Study Coordinator: Lauren Thomas, B.A.

Funding Source: NIH-NCI National Cancer Institute

Study Description:

Our overall goal in this program of research is to eliminate disparities in cancer mortality of patients with SMI. With this proposed single-site RCT, we will assess the preliminary efficacy of the PPC model and create an implementation strategy that can be tested in a larger scale , RO1-funded trial to investigate the effectiveness of PPC in improving cancer care for patients with SMI and their caregivers.

Principal Investigator(s): Kelly Irwin, M.D., MPH

Project Director: Emily Gorton, MPH

Study Sites: MGH

Study Coordinator(s): Samar Shaqour, B.S.; Lauren Thomas, B.A.

Funding Source: PCORI

Study Description:

In this study, we aim to 1) identify barriers and facilitators to engagement and use of technology among vulnerable older adults with SMI, their caregivers, and clinicians during the COVID-19 pandemic and 2) capture emerging research questions, create a shared agenda for patient-centered research, and co-design and disseminate a toolkit for virtual engagement for older adults with SMI.

Principal Investigator(s): Lara Traeger, Ph.D.

Project Director: n/a

Study Sites: Senior living communities in Maryland, Massachusetts, Texas, and Colorado

Study Coordinator(s): Reid Anctil, B.S.; Madeleine Scully, B.A.; Riley Psenka, B.S.

Funding Source: Davis Family Foundation

Study Description:

We conducted a single-arm study to evaluate a 9-session mind-body intervention among older adults residing in four senior living communities. We investigated intervention feasibility, acceptability and preliminary changes in resilience and flourishing. Community residents who consented to participate completed surveys before and after the intervention. We also conducted in-depth exit interviews with a subset of participants. The intervention was delivered by trained clinicians within each community. Results showed that the intervention was feasible and acceptable for community residents. Participants perceived value in practicing mind–body strategies in a group setting, and showed a pattern of improvements in resilience, flourishing, and intervention targets. Findings provided insights for mind–body interventions and recommendations for adaptations to late-in-life concerns and community settings.

Principal Investigator(s): Lara Traeger, Ph.D.

Project Director: n/a

Study Sites: Senior living communities in Virginia, New Jersey, Michigan, North Carolina, Maryland, Massachusetts, Texas, and Colorado

Study Coordinator(s): Reid Anctil, B.S.; Madeleine Scully, B.A.; Riley Psenka, B.S.

Funding Source: Davis Family Foundation

Study Description:

We are conducting a randomized controlled trial to assess the impact of a 9-session mind-body intervention on resiliency, flourishing, and other outcomes among older adults residing in senior living communities across the country. Community residents who consent to study participation will complete surveys at baseline, 3 months, and 6 months. After the baseline survey, participants will be randomly assigned to receive the mind-body intervention immediately or after 6 months. The intervention will be delivered by trained clinicians within each community. All other study procedures and clinical group supervision will be conducted by the study team. Outcomes will be compared between the two groups at 3 and 6 months.

Principal Investigator: Giselle Perez, Ph.D.

Project Director: n/a

Study Sites: MGH

Study Coordinator: Michaela Markwart, B.A.

Funding Source: NCI

Study Description:

Bounce Back is a pilot randomized waitlist-control trial of a highly scalable virtual group program aimed at promoting stress management and coping among post-treatment adolescent and young adult cancer survivors. Bounce Back was adapted from an existing evidence-based resiliency program, the Stress Management and Relaxation Training Relaxation Response Resiliency Program.

Principal Investigators: Gina Kruse, M.D.; Yuchiao Chang, Ph.D.; Elyse Park, Ph.D.

Site PI: Jordan Neil, Ph.D.

Study Sites: MGH; University of Oklahoma Health Sciences Center (OUHSC)

Study Coordinator: Reid Anctil, B.S.

Funding Source: National Comprehensive Cancer Network; AstraZeneca

Study Description:

The goal of this study is to understand the emotional and attitudinal impact of the COVID-19 pandemic and vaccination status on both lung cancer screening (LCS) intentions as well as LCS completion. This study will explore this in both rural and urban settings by investigating patient and provider level barriers to LCS in two geographically diverse healthcare systems in the context of COVID-19. First, this two-year study will work to understand patient health beliefs and psychological barriers and facilitators to lung cancer screening in the context of COVID-19 via cross-sectional, mixed-methods survey. Informed by the survey, investigators will create a community advisory board (CAB) with patient advocates and provider stakeholders representing rural and urban care settings. The CAB will aid in: reviewing survey data in order to identify patients at risk for not completing screenings; identifying the feasibility and acceptability of patient outreach strategies to address barriers and leverage facilitators; and creating a set of recommendations for modifications to provider guidelines and communication strategies for eligible patients. An AstraZeneca-affiliated lung cancer advocacy group, LUNGevity, will also aid in the development of patient-facing content and advocacy materials that will be disseminated through LUNGevity’s community network.

Principal Investigator: Elyse Park, Ph.D.; Gaurdia Banister, Ph.D.

Project Director: n/a

Study Sites: Massachusetts League of Community Health Centers, Massachusetts General Hospital, and the Yvonne L. Munn Center for Nursing Research

Study Coordinator: Isabelle Miranda, B.S., B.A.

Funding Source: U.S. Health Resources and Services Administration (HRSA)

Study Description:

The prolonged strain of the COVID-19 pandemic has taken an emotional toll on healthcare workers who continuously face resource-constraints, perpetual uncertainty about the overall impact and duration of the pandemic, changes in clinical knowledge and guidelines, and the high rates of patient mortality and morbidity. The goals of this project are to (1) identify and implement evidence-based informed programs that promote resilience, wellness, and mental health among the health center workforce serving in rural and medically underserved areas of Massachusetts and (2) to enhance organizational cultures at these health centers to move towards a sustainable model for enhancing employee mental health and wellness.

Principal Investigator(s): Elyse Park, Ph.D., MPH.; Areej El-Jawahri, M.D.

Project Director: Brett Goshe, Ph.D.

Study Sites: MGH

Study Coordinators: Isabelle Miranda, B.S., B.A., Joanna Cloutier, B.A.

Funding Source: National Cancer Institute

Study Description:

ForTe (Forward Together) is a randomized controlled trail assessing an evidence-based mind-body group resiliency treatment, the Stress Management and Resiliency Training-Relaxation Response Program (SMART-3RP) to intervene on 48 cancer survivors and their caregivers. Caregivers are a growing population who experience significant distress as they support patients throughout the cancer continuum. To ameliorate the deleterious health effects of chronic stress, there is a critical need to build caregivers’ resiliency and coping skills. The aims of the study are to determine the feasibility and acceptability of the SMART-3RP for cancer caregivers and survivors, to determine the preliminary efficacy of the MSART-3RP for improving resiliency in caregivers and survivors, and to explore effects of SMART-3RP on caregivers’ and survivors’ health care utilization.

Principal Investigator(s): Elyse Park, Ph.D., M.P.H.; Lucy Finkelstein Fox, Ph.D.

Project Director: n/a

Study Site(s): MGH Cancer Center

Study Coordinator: Isabelle Miranda, B.S., B.A.

Funding Source: Osher Center for Integrative Medicine

Description: Many female colorectal and anal cancer survivors experience a unique, and often poor, sexual quality of life due to the long-term side effects of treatment and surgeries in the pelvic region. Sexual concerns which arise from these physical changes can have indirect effects on psychological and relational factors, such as body image, libido, and ability to enjoy intimacy. The aim of this study is to inform intervention development to optimize the application of existing mind body practices to meet female colorectal and anal cancer survivors’ specific needs for sexual well-being. Focus groups with clinicians and interviews with cancer survivors will identify areas of unmet need and inform our adaptation of existing mindfulness and cognitive-behavioral therapy (CBT) approaches into sexual well-being for GI cancer survivors. Ultimately, we will conduct an open pilot trial to establish feasibility and acceptability of this novel intervention. 

Principal Investigator: Christina Psaros, Ph.D.

Project Director: N/A

Study Site(s): MatCH Research Unit, Durban, South Africa

Study Coordinator: Alexa Rivas, B.A.

Funding Source: National Institute of Mental Health (NIMH)

Description: South Africa (SA) has the largest HIV epidemic in the world, and nurses constitute the largest group of providers in SA’s healthcare system and are frontline treaters in HIV care. Nurses in the public sector experience extremely high levels of stress as a result of limited resources, hindering their ability to provide effective care – a situation that has been exacerbated by the ongoing COVID-19 pandemic. The aim of this study is to tailor the Relaxation Response Resiliency Program (3RP) to the needs of nurses providing HIV care in the public sector in SA to build resilience and reduce stress, and ultimately improve patient-related outcomes. Focus groups will be conducted to explore the ways in which the 3RP requires adaptation to meet the needs of this population. We will then adapt the intervention accordingly and conduct a small proof-of-concept study, followed by a randomized pilot study, to test the feasibility and acceptability of all study procedures, with the goal of developing a scalable intervention that could be used across similar settings worldwide to improve the treatment and care of persons living with HIV (PLWH).

Principal Investigator(s): Efren Flores

Project Director: n/a

Study Sites: Massachusetts General Hospital (MGH)

Study Coordinator: Lauren Thomas, B.A.

Funding Source: NCI

Study Description: 

Lung cancer remains the leading cause of cancer-specific mortality in the U.S., and Hispanics experience worse lung cancer outcomes due to advanced stage at presentation. Lung cancer screening (LCS) can save many lives through early detection, but without increasing efforts to improve smoking status disclosure and documentation and tailored interventions to promote LCS uptake among Hispanic communities, disparities in lung cancer survival will persist. Therefore, this proposal aims to 1) elucidate barriers and facilitators to consistent identification and documentation of smoking status to promote LCS uptake; 2) assess feasibility, acceptability, and reach of the digital delivery of an educational video to promote LCS; 3) explore the effect of the digital delivery of the educational video to increase interest, intent, and scheduling of LCS uptake among eligible Hispanic patients.

Principal Investigator(s): Elyse Park, Ph.D.; Melissa Simon, M.D.

Project Director: Cayla Iwaniuk, MS

Study Sites: NCI Community Oncology Research Program (NCORP) Community Sites and Minority/Underserved Community Sites

Study Coordinator: n/a BUT STUDY NAVIGATOR is Irina Gonzalez, M.D.

Funding Source: NIH, NCI

Study Description:

Inadequate diversity in clinical trials is widely recognized as a significant contributing factor to health disparities experienced by racial/ethnic minorities and other diverse populations in the US. Clinical Trial participation among Black and Latino populations continues to fall short and the multitude of structural, clinical, physician, and patient barriers warrant multilevel interventions to enhance referral and enrollment of Black and Latino patients to NCI-supported CTs. The ECOG-ACRIN Cancer Research Group (EA), as an NCORP Research Base, has engaged community providers and researchers through a robust research portfolio that spans Cancer Control, Cancer Prevention, and Cancer Care Delivery. The multilevel EA SUPPORT intervention consists of a CT research literacy tool and CT Resource Navigators based at EA who will interface with patients, providers, and community oncology site staff to improve referral and enrollment of Black and Latino patients to CTs. Our specific aims are to: 1) Conduct preliminary assessments and refine the EA SUPPORT intervention with focus on community representation and input. 2) Conduct a Hybrid Type 1 cluster-randomized, roll-out effectiveness-implementation trial in 10 NCORP community oncology practice sites (with N= 500 Black and Latino patients with cancer) to evaluate the effectiveness of the EA SUPPORT intervention in improving Black and Latino patient referral and enrollment to NCI-supported CTs (primary outcomes) and participant and provider awareness and knowledge of CTs (secondary outcomes) while assessing implementation factors. 3) With the CUSP2CT Data, Evaluation, and Coordinating Center, conduct final site evaluation and disseminate the SUPPORT intervention to NCORP community oncology sites, research bases, and affiliated trial networks.

Principal Investigator(s): Elyse Park, Ph.D.; Karen Kuhlthau, Ph.D.

Project Director: Brett Goshe, Ph.D.

Study Sites: Massachusetts Federation for Children with Special Needs

Study Coordinator: Isabelle Miranda

Funding Source: NIH, NCCIH

Study Description:

Parents of children with learning and attentional disabilities (LAD) face ongoing stress that leads to deleterious mental and physical health outcomes.. Partnering with the Federation for Children with Special Needs (FCSN) we will further adapt the SMART-LAD intervention in this R56 and the Health Education Program (HEP) attention matched control intervention with diverse parents (or guardians as parents) throughout Massachusetts, including BIPOC (Black, Indigenous, and People Of Color), Latinx, and low-income, rural, and other underserved groups. The aims are: A1: To conduct focus groups to elicit feedback on recruitment plan and tool, intervention delivery and timing, intervention content (SMART-LAD and HEP), and cultural and Spanish language modifications. Five live video-based focus groups will be run: 1 professional group, 2 English speaking parent groups (1 SMART-LAD and 1 HEP), and 2 Spanish speaking parent groups (1 SMART-LAD and 1 HEP). A2: To integrate focus group findings to develop adapted and translated treatments. A3: To conduct 4 pilot groups (SMART-LAD and HEP in English and Spanish) and finalize adapted and translated treatments

Principal Investigator(s): Daniel L. Hall, PhD

Project Director: Daniel L. Hall, PhD

Study Sites: MGH

Study Coordinator: Caleb Bolden

Funding Source: National Institutes of Health, NCI R21

Study Description: 

Optimize synchronous, virtual CBT-I for cancer survivors (Survivorship Sleep Program; SSP) in a factorial trial, explore study participation and sleep outcomes among racial and ethnic minority cancer survivors with insomnia using feasibility benchmarks established in our previous pilot trial, and characterize the acceptability of the SSP design components via exit interviews to characterize preferences, challenges, and future intervention delivery considerations.

Principal Investigator(s): Daniel Hall, PhD

Project Director: Daniel Hall, PhD

Study Sites: MGH

Study Coordinator: Caleb Bolden

Funding Source: National Institutes of Health, NCCIH K23

Study Description:

Position the candidate to become an independent clinical researcher with expertise in refining and testing mind-body interventions for managing fears of illness recurrence and associated healthcare engagement among medical patients, including a research project that will adapt and pilot test a multimodal, mind-body intervention target fear of recurrence among cancer survivors.

Principal Investigator(s): Daniel Hall, PhD

Project Director: Daniel Hall, PhD

Study Sites: MGH

Study Coordinator: Caleb Bolden

Funding Source: American Cancer Society, Research Scholar Grant

Study Description:

Evaluate the efficacy of synchronous, virtual CBT-I for cancer survivors in a randomized controlled trial, with enrollment stratified by survivorship phase (curevivors, metavivors, and in treatment).

Principal Investigator(s): Daniel Hall, PhD

Project Director: Daniel Hall, PhD

Study Sites: MGH

Study Coordinator: Blane Zhu, Samreen Sethi

Funding Source: MGH Development Office, Once Here Foundation

Study Description:

A series of quality improvement, qualitative, and intervention studies aiming to understand and support needs of patients with ME/CFS.

Principal Investigator(s): Wagner (Co-I; Daniel Hall)

Project Director: Pamela Raper

Study Sites: NCORP ECOG-ACRIN sites

Study Coordinator: Coordinated through UNC Gillings School of Public Health

Funding Source: National Institutes of Health, NCI R01

Study Description:

Evaluate an eHealth intervention for reducing fear of recurrence among breast cancer survivors in community oncology settings.

Principal Investigator(s): Greer and Temel (Co-I; Daniel Hall)

Project Director:

Study Sites: MGH

Study Coordinator: 

Funding Source: American Cancer Society, Research Scholar Grant

Study Description:

Evaluate the PROMOTE app study to improve physical function and wellness in patients with lung cancer in a randomized controlled trial. 

Principal Investigator(s): Loughan and Braun (Co-I; Daniel Hall)

Project Director:

Study Sites: Virginia Commonwealth University School of Medicine

Study Coordinator: 

Funding Source:National Institutes of Health, NCCIH R34

Study Description:

This intervention development study aims to develop a fear of recurrence intervention for patients with glioma.